Raised Plasma Homocysteine: An Emerging Risk Factor for Ischaemic Heart Disease
Author(s) -
MS Kabir,
AAS Majumder,
AW Chowdhury,
S Haque,
AQM Reza,
AEMM Islam,
ARM Saifuddin Ekram,
Riaz Uddin,
QT Islam
Publication year - 1970
Publication title -
taj journal of teachers association
Language(s) - English
Resource type - Journals
eISSN - 2408-8854
pISSN - 1019-8555
DOI - 10.3329/taj.v19i2.3158
Subject(s) - homocysteine , medicine , fibrinogen , plasminogen activator , diabetes mellitus , risk factor , pathogenesis , vascular disease , endocrinology , family history , ischaemic heart disease , cardiology
Only one half to two thirds of atherosclerotic vascular diseases can be explained by classical risk factors like smoking, diabetes mellitus, hypertension, dyslipidaemia, family history of premature atherosclerotic vascular diseases, physical inactivity, obesity etc. Some other variables appear to contribute to the development of atherosclerotic vascular diseases which include estrogen deficiency, lipoprotein (a), plasma fibrinogen, plasminogen-activator inhibitor type I, endogenous tissue plasminogen activator (tPA), C-reactive protein and homocysteine. Over the last several years, investigators undertook extensive research work, in home and abroad, to determine the contribution of plasma homocysteine in the pathogenesis of atherosclerotic vascular diseases. So far the research work indicates, raised plasma homocysteine appears to be a potential risk factor for ischaemic heart disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom